(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ADAPT PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ADAPT PHARMA

ST13

US500000086982631

Class

5

Filing

86982631

Registration

5272205

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

73

Latest update

10/02/2024

Trademark type

Word

Nice classes

5

Filing date

11/27/2013

Registration date

08/22/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/09/2024

Last transaction

08/09/2024

Responsible office

United States Patent and Trademark Office

Status code

702

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2016-02-00

First use in commerce

2016-02-00

Drawing code

4

Owner type

24

Owner location

DUBLIN, IE

Examiner

MACFARLANE, JAMES W

Current location

Historical data usage

Holders and representatives

Holders

EMERGENT BIOSOLUTIONS IRELAND LIMITED
Adapt Pharma Limited

Representatives

Mainak H. Mehta Procopio, Cory, Hargreaves and Savitch LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Medicated and pharmaceutical preparationsboth prescription and over-the-counterfor the treatment or prevention of conditions in the areas of central nervous systempainaddictionall of the foregoing unrelated to ostomy products and preparations

Publications

History of USPTO decisions and trademark events.

73 publications found

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

10/02/2024

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

09/18/2024

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

08/09/2024

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

08/09/2024

EROP

TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED

06/29/2024

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/28/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/28/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/28/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/28/2024

PR23

POST REGISTRATION ACTION MAILED - SEC. 8 & 15

01/10/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/10/2024

E815

TEAS SECTION 8 & 15 RECEIVED

07/15/2023

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

08/22/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/23/2022

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

06/16/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/12/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/12/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/03/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/03/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

08/22/2017

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/18/2017

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

07/15/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/04/2017

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/03/2017

EX5G

SOU EXTENSION 5 GRANTED

07/03/2017

DPCC

DIVISIONAL PROCESSING COMPLETE

07/03/2017

IROA

RESPONSE TO ITU OFFICE ACTION ENTERED

06/29/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/29/2017

INCD

ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST

06/29/2017

EXT5

SOU EXTENSION 5 FILED

06/13/2017

EEXT

SOU TEAS EXTENSION RECEIVED

06/13/2017

IUAF

USE AMENDMENT FILED

06/08/2017

DRRR

DIVISIONAL REQUEST RECEIVED

06/08/2017

EISU

TEAS STATEMENT OF USE RECEIVED

06/08/2017

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/08/2017

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/01/2016

EX4G

SOU EXTENSION 4 GRANTED

11/30/2016

EXT4

SOU EXTENSION 4 FILED

11/15/2016

EEXT

SOU TEAS EXTENSION RECEIVED

11/15/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/24/2016

EX3G

SOU EXTENSION 3 GRANTED

05/21/2016

EXT3

SOU EXTENSION 3 FILED

05/09/2016

EEXT

SOU TEAS EXTENSION RECEIVED

05/09/2016

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/30/2016

EX2G

SOU EXTENSION 2 GRANTED

01/29/2016

EXT2

SOU EXTENSION 2 FILED

12/22/2015

EEXT

SOU TEAS EXTENSION RECEIVED

12/22/2015

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/23/2015

EX1G

SOU EXTENSION 1 GRANTED

05/22/2015

EXT1

SOU EXTENSION 1 FILED

05/14/2015

EEXT

SOU TEAS EXTENSION RECEIVED

05/14/2015

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

12/23/2014

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/28/2014

PUBO

PUBLISHED FOR OPPOSITION

10/28/2014

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/08/2014

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

09/23/2014

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/22/2014

DPCC

DIVISIONAL PROCESSING COMPLETE

08/12/2014

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/12/2014

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/17/2014

ALIE

ASSIGNED TO LIE

07/07/2014

DRRR

DIVISIONAL REQUEST RECEIVED

06/27/2014

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/27/2014

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/27/2014

ERTD

TEAS REQUEST TO DIVIDE RECEIVED

06/27/2014

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/19/2014

GNRT

NON-FINAL ACTION E-MAILED

03/19/2014

CNRT

NON-FINAL ACTION WRITTEN

03/19/2014

DOCK

ASSIGNED TO EXAMINER

03/12/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/11/2013

NWAP

NEW APPLICATION ENTERED

11/30/2013

Continuous trademark protection

Get notified about every new filing that threatens ADAPT PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.